76 related articles for article (PubMed ID: 1671167)
1. Prolactin and breast cancer risk.
Beumont PJ
Med J Aust; 1991 Feb; 154(3):219. PubMed ID: 1671167
[No Abstract] [Full Text] [Related]
2. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
4. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and breast cancer risk.
Tworoger SS; Hankinson SE
Cancer Lett; 2006 Nov; 243(2):160-9. PubMed ID: 16530327
[TBL] [Abstract][Full Text] [Related]
6. Possible linkage between the ability to change the period (tau) of the prolactin and cortisol rhythms in women and breast cancer risk.
Lewy H; Haus E; Ashkenazi IE
Chronobiol Int; 2007; 24(2):365-81. PubMed ID: 17453854
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma prolactin levels in a group of men with breast cancer--a preliminary study.
Olsson H; Alm P; Aspegren K; Gullberg B; Jönsson PE; Ranstam J
Anticancer Res; 1990; 10(1):59-62. PubMed ID: 2110433
[TBL] [Abstract][Full Text] [Related]
9. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
[TBL] [Abstract][Full Text] [Related]
10. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
11. The basal and TRH stimulated levels of prolactin in low risk climacteric patients with increased breast density: a matched pair case control trial.
Soysal S; Soysal ME; Karabulut N; Gul N; Gezgin T
Maturitas; 2006 May; 54(2):103-9. PubMed ID: 16530361
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in hospitalized psychiatric patients.
Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
[TBL] [Abstract][Full Text] [Related]
14. [Prolactin and human cancer of the breast. I. Levels of correlation].
Cueto Ladrón de Guevara J; Villalba Moreno J; García Puche JL; Pedraza V
Rev Esp Oncol; 1985; 32(3):439-58. PubMed ID: 3870536
[TBL] [Abstract][Full Text] [Related]
15. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
Pavić S; Pavić Z
Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women.
Falk RT; Brinton LA; Madigan MP; Potischman N; Sturgeon SR; Malone KE; Daling JR
Breast Cancer Res Treat; 2006 Jul; 98(2):157-65. PubMed ID: 16502016
[TBL] [Abstract][Full Text] [Related]
17. [Prolactin and cancer of the breast].
Marugo M; Giusti M; Bolognesi F; Reitano A
Boll Soc Ital Biol Sper; 1977 Apr; 53(8):675-8. PubMed ID: 907746
[No Abstract] [Full Text] [Related]
18. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
19. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.
Ross RK; Paganini-Hill A; Krailo MD; Gerkins VR; Henderson BE; Pike MC
Cancer Res; 1984 Jul; 44(7):3106-8. PubMed ID: 6722826
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.
Liu-Seifert H; Kinon BJ; Ahl J; Lamberson S
Ann N Y Acad Sci; 2004 Dec; 1032():297-8. PubMed ID: 15677434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
